NCT06670443 Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients
| NCT ID | NCT06670443 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Chronic Obstructive Pulmonary Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-01-10 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-01-10 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Electrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles In addition to conventional pulmonary rehabilitation
Eligibility Criteria
Inclusion Criteria: * Patient undergoes four main clinical criteria for the diagnosis of RLS according to the international restless leg syndrome study group (IRLSSG) including 1. an urge to move legs that is usually associated with paresthesia. 2. alleviation of the symptoms by moving the legs. 3. aggravation or exacerbation of the symptoms particularly at rest or during sitting or lying down in the bed. 4. worsening of the signs at night. patients with diagnosed with grade I and grade II COPD their ages ranged between 45-55 o All patients will be clinically and medically stable when attending the study Exclusion Criteria: * History of Deep venous thrombosis * History of Bleeding disorders * Have an implantable device like a pacemaker * Recent Infected wound * History of allergic response to the electrodes, gel or tape * patients who participating in any other exercise program * Loss of sensation or numbness
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06670443 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06670443 currently recruiting?
Yes, NCT06670443 is actively recruiting participants. Contact the research team at malahmarirrt@gail.com for enrollment information.
Where is the NCT06670443 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT06670443 clinical trial?
NCT06670443 is sponsored by Cairo University. The trial plans to enroll 60 participants.